BofA analyst Joshua Dennerlein lowered the firm’s price target on Medical Properties Trust (MPW) to $3 from $3.50 and keeps an Underperform rating on the shares. The firm continues to believe the company is in a “difficult situation,” with the key concern surrounding its ability to pay off or refinance its debt maturing in 2026 or 2027, the analyst tells investors.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MPW:
- Medical Properties Trust prospect to sell managed care unit to Astrana for $745M
- Medical Properties Trust Reports Q3 2024 Results
- Medical Properties Trust reports Q3 normalized FFO 16c, consensus 20c
- MPW Upcoming Earnings Report: What to Expect?
- Medical Properties: Independent investigation found no evidence of wrongdoing